Keywords: nanoparticle, formulation, gsk, compound, nanocarrier, japan, entered

Nanoparticle formulation for GSK compound.

Article | 21 January 2002

Print This

NanoCarrier of Japan has entered into an agreement with GlaxoSmithKline to carry out exploratory studies to determine the feasibility of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in